positive 1-year safety and biomarker data for huntington disease gene therapy
Published 2 years ago • 1K plays • Length 4:55Download video MP4
Download video MP3
Similar videos
-
20:58
developing biomarkers for huntington's disease
-
8:18
targeted therapy for huntington disease
-
4:03
huntington disease overview
-
2:20
what physicians should know about gene therapy
-
3:29
positive interim data in gene therapy trial for gm1 gangliosidosis
-
3:47
biomarkers for therapeutic development in huntington’s disease
-
11:31
the limitations of current treatment options for huntington’s disease and spinocerebellar ataxia
-
3:42
gene therapy clinical trial for frontotemporal dementia has begun
-
4:41
huntington's disease overview and the generation hd1 study
-
4:14
update on huntingtin-lowering strategies under investigation for huntington’s disease
-
59:38
dr richard myers micrornas in csf as prodromal biomarkers for huntington’s disease
-
3:26
update on roche’s antisense drug (rg6042) for huntington’s disease
-
19:54
the brain conference 2021: new genetic therapies for huntington’s disease (sarah tabrizi)
-
28:03
genetics and gene therapy in huntington's disease - 2022 hd educational symposium
-
3:32
radical change in the huntington disease research landscape
-
1:55
raising awareness for huntington's disease
-
4:50
huntington's disease genetic testing process - rhona macleod
-
1:34
first gene therapy trial in huntington's disease
-
1:56
strategies to improve asos in huntington’s disease